Apogee Therapeutics, Inc. (NASDAQ:APGE) Given Average Recommendation of “Buy” by Brokerages
Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) have been given a consensus rating of “Buy” by the seven brokerages that are covering the company, MarketBeat reports. Seven research analysts have rated the stock with a buy rating. The average 12 month target price among brokers that have covered the stock in the […]
More Stories
AXIS Capital Holdings Limited (NYSE:AXS) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of AXIS Capital Holdings Limited (NYSE:AXS – Get Free Report) have received an average rating of “Moderate Buy” from...
AXIS Capital Holdings Limited (NYSE:AXS) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of AXIS Capital Holdings Limited (NYSE:AXS – Get Free Report) have received an average rating of “Moderate Buy” from...
Cameco Co. (TSE:CCO) Receives C$84.30 Average PT from Brokerages
Shares of Cameco Co. (TSE:CCO – Get Free Report) (NYSE:CCJ) have been assigned a consensus recommendation of “Buy” from the...
Cameco Co. (TSE:CCO) Receives C$84.30 Average PT from Brokerages
Shares of Cameco Co. (TSE:CCO – Get Free Report) (NYSE:CCJ) have been assigned a consensus recommendation of “Buy” from the...
Brokerages Set Amgen Inc. (NASDAQ:AMGN) Price Target at $318.83
Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the twenty-seven...
Brokerages Set Amgen Inc. (NASDAQ:AMGN) Price Target at $318.83
Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the twenty-seven...